<DOC>
	<DOCNO>NCT02033421</DOCNO>
	<brief_summary>The recommended length antibiotic treatment patient infective endocarditis 4-6 week . All patient receive dosis except renal impairment receive small dose . For Beta-lactam antibiotic , plasma concentration minimal inhibitory concentration ( MIC ) least 50 % time dose interval maximize bactericidal activity . To estimate time antibiotic concentration MIC ( T &gt; MIC ) see might relationship concentration antibiotic possible side-effects , toxicity treatment failure , patient admit infective endocarditis follow two blood test withdraw week antibiotic treatment , expect average 5 week .</brief_summary>
	<brief_title>Beta-lactam Pharmacokinetics Patients With Infective Endocarditis</brief_title>
	<detailed_description>Comorbidity common patient admitted infective endocarditis may effect pharmacokinetics antibiotic . The dose antibiotic may therefore result different plasma concentration different patient , might influence possible side-effects , toxicity treatment failure . To investigate , patient admit infective endocarditis , treat Beta-lactam antibiotic , follow two blood test withdraw week antibiotic treatment , expect average 5 week . Beta-lactam administer every 6th hour . The first blood test withdrawn three hour antibiotic infusion . The second blood test withdrawn right next antibiotic infusion . There intervention study , result observational . The result contribute assess efficacy quality treatment help evaluate whether plasma concentration antibiotic take routine blood test every week patient infective endocarditis .</detailed_description>
	<mesh_term>Endocarditis</mesh_term>
	<mesh_term>Endocarditis , Bacterial</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>Patients admit infective endocarditis Treatment Betalactam antibiotic Under 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Infective endocarditis</keyword>
	<keyword>Therapeutic drug monitoring</keyword>
</DOC>